Sommadossi Jean-Pierre — SEC Form 4 filings
SEC reporting owner CIK 1296995. 5 Form 4 filings on record with FilingPulse; latest filed 2026-02-03.
Transaction summary — filings shown
Covers all 5 filings on record, filed 2024-02-02 to 2026-02-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 3 filings — 115,885 shares, $456,998 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: sale of 56,910 shares @ $3.85 ($218,819) in Atea Pharmaceuticals, Inc., filed 2024-02-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Atea Pharmaceuticals, Inc. (AVIR) | President, CEO, and Chairman, Director | 5 | — | 5 legs · 115,885 sh · $456,998 | 15 |
Form 4 filings — Sommadossi Jean-Pierre
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-03 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Option exercise (M): 272,983 · Tax withholding (F): 106,093 @ $4.24 · Option exercise (M): 300,000 @ $1.24 · Option exercise (M): 173,466 (derivative) @ $0 · Option exercise (M): 99,517 (derivative) @ $0 · Option exercise (M): 300,000 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Option exercise (M): 173,467 · Grant/award (A): 99,517 · Tax withholding (F): 88,601 @ $3.06 · Option exercise (M): 173,467 (derivative) @ $0 · Grant/award (A): 99,518 (derivative) @ $0 · Grant/award (A): 440,000 (derivative) @ $0 | EDGAR |
| 2024-09-19 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Sale (S): 33,941 @ $4.05 · Sale (S): 22,187 @ $4.03 · Sale (S): 1,841 @ $4.00 | EDGAR |
| 2024-06-07 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Sale (S): 1,006 @ $4 | EDGAR |
| 2024-02-02 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Option exercise (M): 173,467 · Sale (S): 56,910 @ $3.85 · Option exercise (M): 173,467 (derivative) @ $0 · Grant/award (A): 448,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1296995 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →